Innate Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Innate Pharma stock prices and determine the direction of Innate Pharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Innate Pharma's historical fundamentals, such as revenue growth or operating cash flow patterns.
Innate
On December 2, 2024 Innate Pharma had Day Typical Price of 1.39. Typical Price is calculated as arithmetic average of the high, low and closing price for a given trading period.
On December 03 2024 Innate Pharma was traded for 1.37 at the closing time. The maximum traded price for the trading interval was 1.38 and the lowest daily price was 1.35 . The daily volume was recorded at 28.2 K. The volume of trading on 3rd of December 2024 did not cause price change. The trading delta at closing time to the closing price today is 1.46% .
The period considered in calculating typical price is a single trading day, however the typical price can also be applied to other time spans such as a week, month or year.
For every potential investor in Innate, whether a beginner or expert, Innate Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Innate Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Innate. Basic forecasting techniques help filter out the noise by identifying Innate Pharma's price trends.
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Innate Pharma stock to make a market-neutral strategy. Peer analysis of Innate Pharma could also be used in its relative valuation, which is a method of valuing Innate Pharma by comparing valuation metrics with similar companies.
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Innate Pharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Innate Pharma's current price.
Market strength indicators help investors to evaluate how Innate Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Innate Pharma shares will generate the highest return on investment. By undertsting and applying Innate Pharma stock market strength indicators, traders can identify Innate Pharma entry and exit signals to maximize returns.
The analysis of Innate Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Innate Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting innate stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Information and Resources on Investing in Innate Stock
When determining whether Innate Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innate Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innate Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innate Pharma Stock:
Please note, there is a significant difference between Innate Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innate Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innate Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.